Literature DB >> 30891569

Determination of median effective dose (ED50) of scorpion antivenom against scorpion envenomation using a newly developed formula.

Saganuwan Alhaji Saganuwan1.   

Abstract

BACKGROUND: About 50 species of scorpions cause fatal scorpionism worldwide. Most of these are members of the Buthidae family, and include, among others, Mesobuthus eupeus, Androctonus crassicauda, Leiurus abdullahbayrami, Leiurus quinquestriatus, Tityus pachyurus and Androctonus australis. Because high doses of scorpion venom and antivenom can cause death and hypersensitive reactions, there is a need to develop a formula that can be used to calculate both lethal and effective doses for scorpion venom and antivenom, respectively, thereby obviating the need for laboratory experiments.
METHODS: In view of this, a literature search was carried out with the aim of modifying the formula ( LD 50 = ED 50 3 × W a × 10 - 4 ) for calculation of the median lethal dose (LD50) of scorpion venom and the ED50 of antivenom. The human equivalent dose (HED) formula was assessed for extrapolation of LD50 and ED50 from animals to human for comparison and relevance with the new formula.
RESULTS: The findings showed that the newly developed formula (LD50 = ED50 1/3 × W a  × 10-4) yielded results that are very close to the reported values. Therefore, the newly developed and HED formulas can be used for calculation of LD50 and ED50 values for scorpion venom and antivenom, respectively.
CONCLUSION: The new formula yielded better results than the HED formula, confirming its predictive validity, precision, and reliability, thereby obviating the need for rigorous experiments and justifying the principles of reduction, refinement, and replacement (3Rs).

Entities:  

Keywords:  ED50; LD50; Scorpion; antivenom; human equivalent dose; venom

Year:  2018        PMID: 30891569      PMCID: PMC6388075          DOI: 10.1002/ame2.12031

Source DB:  PubMed          Journal:  Animal Model Exp Med        ISSN: 2576-2095


INTRODUCTION

Scorpions are members of the order Scorpiones, class Arachnida, subgroup Arthropoda. Their poisonous stings (termed scorpionism) have caused innumerable deaths, and scorpionism has raised serious concern worldwide because of its high incidence, prevalence, morbidity, and mortality.1 About 2.3 billion people from Africa, the near and Middle‐East and South India are at risk, and annual stings of over 1.2 million are reported, resulting in 3250 deaths, with higher severity and mortality among children.2 However, mortalities have decreased in countries that use antivenoms.3 Scorpionism caused by Tityus pachyurus polock is characterized by sialorrhea, respiratory distress, profuse sweating, ataxia, restlessness, somnolence, and hypoglycemia in mice. However, the antivenoms Bioclon and Butantan, produced in Mexico and Brazil, respectively, are very effective against T. pachyurus Pocock.4 The toxicity of the venom is related to the maturity and weight of the scorpion.5 Out of 1500 species of scorpions, 46‐50 species are lethal. The number of dangerous species in the Buthidae family is significantly higher than in other families. Despite the fact that scorpion envenomations are a considerable health problem in tropical and subtropical regions of the world, treatment requires the use of specific antiserum. In 1909, Charles Todd produced a serum that was effective against Buthus quinquestriatus venom by immunizing horses using crude venom as an antigen.6, 7 The treatment requires a high amount of antivenom to yield satisfactory neutralization,8 which can lead to adverse reactions. Hence there is a need to assess the median effective dose (ED50) of scorpion antivenom against the LD50 of the venom, with a view to eliminating or reducing post‐treatment adverse reactions and obviating the need for laboratory experiments.

METHODS

A random search of the literature, including journals, textbooks, books of abstracts, conference proceedings, and other periodicals, was conducted to establish the species of poisonous scorpions, their venoms, antivenoms, median lethal doses (LD50), median effective doses (ED50), their immunogenic reactions and the formulas used for calculation of both LD50 and ED50.6, 7, 9, 10, 11, 12, 13, 14 The following four formulas were extracted. Based on the above formulas, the initial formula () developed by Saganuwan15 is therefore modified to (). A one‐third exponent was used to provide therapeutic scaling of dose translation from animal to animal.16 The new formula was used to estimate ED50 and LD50 values for venom from Mesobuthus eupeus, Androctonus crassicauda, Leiurus abdullahbayrami, Hottentotta saulcyi, Leiurus quinquestriatus and T. pachyurus and Androctonus australis. ED50 and LD50 values were also calculated using the human equivalent dose (HED) formulas, and the two sets of values were compared with the values reported in the literature. Animal‐human and human‐animal ED50 and LD50 values of T. pachyurus venom and antivenom were respectively calculated using the new and human HED formulas. HED is equal to the animal dose multiplied by the animal correction factor (Km) divided by the human Km factor. The Km factor is body weight (kg) divided by body surface area (m2). Body weights and body surface areas of animals and humans were taken from Reagan‐Shaw et al16 and USEPA.17 The ED50s for antivenom against M. eupeus, A. crassicauda and T. pachyurus have been established,4, 6, 9, 10, 11 but were recalculated using the new and HED formulas. The routes of administration are indicated in Table 1.
Table 1

The species of scorpions, average weights of experimental animals, median lethal dose (LD50) and effective dose 50 (ED50) of scorpion venoms and antivenoms

S/noSpecies of scorpionSpecies of experimental animalAverage weight (g)Reported LD50 of scorpion venomReported ED50 of antivenomED50 by the new formulaED50 by HED formulaReference(s)Comments
1 Mesobuthus eupeus Swiss abino mice Rabbit 20 ± 2.0 200 ± 2.0 0.18 mg/kg[Link] i.m. 4.5 mg/kg 1 ml of Androctonus crassicauda neutralized 464 LD50 of M. eupeus in mice 4.5 mg/kg 2.82 mg/kg 0.35 mg/kg 1.0 mg/kg 6, 9 ED50 is unknown
2 Androctonus australis Mice20.0 ± 1.00.5 mg/kg[Link], 12 mg/kg[Link], 0.25 mg/kg16‐18 μg6.3 ng–5 mg/kg0.48 ng‐0.39 mg/kg 18 ED50 is unknown
3 Androctonus crassicauda Swiss albino mice25.0 ± 1.00.27 mg/kg15.45 μg/kg[Link] i.c.v.1.1 mg/kg, 39.19 mg/kg i.v.35 μg/kg[Link] sc.0.8‐1.3 mg/kg1 mL of A. crassicauda antivenom neutralized 940 LD50 of A. crassicauda venom in mice5.1 mg/kg4.6 μg/kg8.2 mg/kg27.0 mg/kg i.v.26.0 μg/kg sc.7.4‐11.5 mg/kg2 0.49 mg/kg0.44 μg/kg0.79 mg/kg2.61 mg/kg2.51 μg/kg0.74‐1.11 mg/kg 6, 7, 10, 11 ED50 is unknown
4 Leiurus abdullahbayrami Mice20.0 ± 2.00.19 mg/kg[Link] sc.4.6 mg/kg0.36 mg/kg 11 ED50 is unknown
5 Hottentotta saulcyi Mice20.0 ± 1.00.73 mg/kg sc.7.1 mg/kg0.55 mg/kg 13 ED50 is unknown
6 Leiurus quinquestriatus Rabbit2000 ± 2000.16‐0.5 mg/kg[Link] 0.93‐1.4 mg/kg0.33‐0.50 mg/kg 19 ED50 is unknown
7 Tityus pachyurus Swiss Webstar mice19.0 ± 1.04.8 μg/kg[Link] 330 μg/mL (Bioclon)292 μg/mL (Butantan)13.6 mg/kg1.0 mg/kg 4 High chance of hypersensitivity reaction

—: No available information.

aHighly toxic.

The species of scorpions, average weights of experimental animals, median lethal dose (LD50) and effective dose 50 (ED50) of scorpion venoms and antivenoms —: No available information. aHighly toxic.

RESULTS

Species of scorpions, experimental LD50s of scorpion venoms, therapeutic ED50 values of scorpion antivenoms and their calculated ED50 values are presented in Table 1. Androctonus australis is the most poisonous among the seven species, followed by T. pachyurus, A. crassicauda, L. quinquestriatus, M. eupeus, Leiurus abdullabayrami and H. saulcyi, in that order (Table 1). Species of animals, their bodyweights, BSAs, km factors, human equivalent doses, calculated LD50s for Tityus pachyurus venom and ED50 values of the antivenom are presented in Table 2.
Table 2

Mouse‐human and human‐other animals extrapolated median lethal dose (LD50) and effective dose 50 (ED50) of Tityus pachyurus venom and antivenom

S/noSpeciesBody weight (kg)BSA (m2)Km factorHED calculated LD50 (μg/kg)HED calculated ED50 (μg/kg)ED50 by the new formula (μg/kg)
1Mouse0.020.0072.94.813.6133.3
2Hamster0.080.024.03.487.675.7
3Rat0.150.0256.02.325.453.7
4Guinea pig0.40.0645.82.403.939.1
5Rabbit1.80.1512.01.161.918.6
6Monkey3.00.2412.51.111.515.5
7Cat7.00.3718.90.741.010.0
8Dog10.00.5020.00.700.98.9
9Baboon12.00.6020.00.700.88.4
10Ferret0.300.0437.01.994.040.5
11Marmoset0.350.065.82.404.140.9
12Squirrel monkey0.60.096.72.083.332.6
13Micro‐pig20.00.7427.00.520.629.6
14Mini‐pig40.01.1435.10.400.521.5
15Child20.00.825.00.560.730.4
16Adult human60.01.637.50.370.44.0

BSA: body surface area; HED: human equivalent dose formula; Km: metabolism constant (body weight [kg] divided by body surface area).

Mouse‐human and human‐other animals extrapolated median lethal dose (LD50) and effective dose 50 (ED50) of Tityus pachyurus venom and antivenom BSA: body surface area; HED: human equivalent dose formula; Km: metabolism constant (body weight [kg] divided by body surface area).

DISCUSSION

The new formula yielded higher estimated doses of scorpion antivenom. The severity of toxicity signs are directly related to LD50. The lower the LD50 value, the more severe the toxicity signs. Therefore, A. australis venom with an LD50 (0.5 ng/kg) is the most dangerous among all the species of scorpions followed by T. pachyurus (4.8 μg/kg) and A. crassicauda (15.45 μg/kg) venom. Our findings are corroborated by a report that Tityus stigmurus envenomation caused death in humans characterized by cardiogenic shock, pulmonary edema, and severe neurological symptoms.20 The effect of scorpion venom on the frequency, but not the amplitude, of spontaneous glycinergic and glutamatergic postsynaptic currents suggests that scorpion toxin acts on inhibitory and excitatory presynaptic nerves.21 Scorpion venom toxicity increases in a dose‐dependent fashion. The decreasing order of acute toxicity of A. australis, T. pachyurus, A. crassicauda, L. quinquestriatus, M. eupeus, L. abdullahbayrami and H. saulcyi venoms shown in Table 1 agrees with a report indicating that members of Buthidae family are of medical importance.12 Androctonus crassicauda scorpion venom has active constituents that could induce a sustained activation of human monocytes, expressed as IL‐12.22 The venom has a distinct molecular mass component, from which two peptides (Acra 1 and Acra 2) have been fully amino acid sequenced. The peptides are similar to known sodium channel‐specific toxins of other scorpions.23 Scorpion antivenom has preventive, neutralizing, and curative properties against M. eupeus scorpionism if applied at optimum time, dose and route.9 The LD50 of A. crassicauda venom has been estimated as 1.1 mg/kg by electrical stimulation and 39.19 mg/kg by maceration of telson.10 This venom has the lowest elimination rate among all known scorpion venoms, making it highly toxic. The long half‐life of the venom suggests the need for long‐acting antivenom for venom neutralization.24 Envenomation by L. abdullahbayrami causes hyperexcitability, agitation, aggressive behavior, squeaking, fighting, tachypnea, weakness, convulsion, and death due to cardiac and respiratory failure in mice.12 Envenomation by L. quinquestriatus produced degranulation of eosinophils, fever, oedema of cerebrum and myocarditis in rabbit.14 The reports confirm the medical importance of members of the Buthidae family. Bio‐distribution of two purified toxic fractions of M. eupeus toxin in mice show rapid clearance of the compounds from blood and tissue, except for the kidneys,25 signifying that M. eupeus toxicity may not last long in the body. Dissociation of the toxin‐channel complex during depolarization is determined by the difference between electrical energies of the activated states of normal and toxin‐modified channels.26 Injection of partially purified toxic fractions into rabbits gave rise to more potent antivenoms than those presently available, generated using whole venom,27 signifying that purification could reduce the dose of antivenoms needed. The antivenom for A. crassicauda venom, with an LD50 (15.45 μg/kg) in mice,10 neutralized Mesobuthus gibosus venom (LD50 20 μg/kg) in the Aegean region of Turkey.6 Thus, highly potent antivenom could be produced from about 238 telsons in 51 days.28 The calculated ED50/LD50 ratios for Butantan (292 μg/mL) and Bioclon (330 μg/mL) antivenoms and tityus toxin, the toxic principle of Tityus species, are and , respectively, which give equivalent weights of 21.5 and 24.3 kg, showing that Butantan (292 μg/mL) and Bioclon (330 μg/mL) antivenoms could be used effectively in the treatment of humans weighing 21.5–24.3 kg, and signifying that age must be considered in the treatment of tityus toxin.29 However, the difference in severity of symptoms observed in children and adults may be due to differences in the pharmacokinetics of the toxin. M. eupeus venom can be neutralized by monovalent, polyvalent and anti‐idiotype antivenoms, which are non‐toxicants and can be used as a vaccine in people at risk of scorpion stings.30 Lack of a reported effective dose of antivenoms for L. abdullahbayrami, L. quinquestriatus, H. saulcyi, M. eupeus and A. crassicauda shows the need for specific antivenoms for a number of scorpion species. Scorpion antivenoms are specific antigens, detoxified venoms, toxins, purified venom fractions, natural toxoids, recombinant toxins, synthetic peptides, and monoclonal and recombinant antibodies.7 Using peptides derived from the sequence of scorpion toxins, the penetration of antipeptide antibodies can neutralize the cognate venom.31 Turkish antivenom against A. crassicauda is effective against other species of scorpions. Minimum lethal dose and minimum effective dose were used to evaluate the effect of Turkish antivenom on M. gibbosus envenomation,18 suggesting the predictive validity, precision, and reliability of the new formula in envenomotherapy. Scorpion stings result in adult morbidity and pediatric mortality1 and the most lethal species are Tityus serrulatus and Tityus bahiensis in Brazil, Centruroides suffusus, Centruroides lionpidus, and Centruroides sculpturatus in Mexico, L. quinquestriatus, A. crassicauda, A. mauretanicus, A. australis, A. amoreuni, and Buthus occitanus in the Middle East and North Africa, Parabuthus grauntatus and Parabuthus transvaalicus in South Africa, and Mesobuthus tamulus and Palamneus swammerdance in India32, 33, 34, 35. Androctonus australis has complex venom that contains cytotoxic principles with very rapid resultant fatal effects.36 Effective monoclonal antibodies (mAbs) specific to the α‐neurotoxin 1 (Aah1) from A. australis hector venom have been reported,37 which also has recombinant toxin II with immunological and biological properties.38 In addition, A. australis hector envenomation is mediated by cytokines and the complement system, which activate in turn to damage tissue.39 Kinins are also involved in cardiovascular toxicity and cause lethality of L. quinquestriatus venom in rabbits.40 A. australis garzonii venom (100 μg/kg) was neutralized by 4 mg/kg of antivenom injected intravenously.41 Antivenoms against a number of scorpion venoms have been reported,42 but the potency of antivenom in relation to the potency of scorpion venom 12 and both LD50 and ED50 should be determined paradoxically and canonically.43 The LD50s of intravenous venom from Vipera berus berus (0.4 μg/kg; symptoms included head‐drop, floppy neck, flaccid paralysis of limb, respiratory paralysis, and death),44 Laticauda colubrine (0.05‐0.13 μg/g),45 Sri Lankan Bungarus caeruleus (0.07 μg/g),46 Naja sputatrix 47 and A. australis (0.5 ng)18 show that the scorpion venoms are highly toxic. Similar symptoms were observed for Vipera nikolskii venom (1.0 μg/kg), but the symptoms, caused by phospholipase A2, were lost after the mice were injected with strontium.18 Hence, strontium may be suitable as an antivenom against V. berus berus and A. australis venoms. The newly developed dot‐ELISA for detection of the venoms of the Indian venomous snakes Naja naja, B. caeruleus, Dabora russelli and Echis carinatus 48 and proteomic enzyme analysis49 may generally be used to detect scorpion venoms. The venoms of Montivipera raddei and Montivipera bubjardahica, which have high levels of toxicity, have been shown to have potent cytotoxicity against AS49 human lung carcinoma,50 signifiying that scorpion venom may also have anticancer properties. Lethal doses of L. quinquestriatus were 0.5 mg/kg i.v. and 3 μg/kg i.m.3 The LD50 of T. pachyurus venom and the ED50 for its antivenom in monogastric animals are presented in Table 2. The results show that mouse (4.8 μg/kg) is the most sensitive to T. pachyurus venom followed by hamster (3.48 μg/kg), guinea pig (2.40 μg/kg), rat (2.32 μg/kg), rabbit (1.16 μg/kg), monkey (1.11 μg/kg), marmoset (2.40 μg/kg), squirrel monkey (2.08 μg/kg), ferret (1.99 μg/kg), cat (0.74 μg/kg), dog and baboon (0.70 μg/kg), child (0.56 μg/kg), micro‐pig (0.52 μg/kg), mini‐pig (0.40 μg/kg) and adult human (0.37 mg/kg) respectively, indicating that T. pachyurus venom is very toxic. The toxicity may be due to the presence of tityutoxins that are also present in T. pachyurus, T. stigmurus, Tityus abscurus and T. serrulatus venom. The toxic principle acts via Na+, K+, Ca2+ and Cl− channels, signifying excitation of heart, CNS, and muscular fibres.51, 52, 53, 54, 55 The reported ED50s (0.4‐13.6 μg/kg) for scorpion antivenoms for all the surveyed species using the HED formula are low, which may lead to therapeutic failure. The higher ED50s (4.0‐133.3 μg/kg) for all the species calculated using the new formula indicate an improved neutralization potential.4 Based on these calculations, the mini‐pig could be the best model for determination of LD50 and ED50 for T. pachyurus venom and antivenom, respectively.

CONCLUSION

This study showed that A. australis venom is the most toxic, followed by T. pachyurus, A. crassicauda, L. quinquestriatus, M. eupeus, L. abdullabayrami, and H. saulcyi. The modified and HED formulas can be used to estimate the LD50 and ED50 values of the scorpion venoms and antivenoms, respectively. The newly developed formula, incorporating safety factor, animal weight and therapeutic index, yielded increased quantities of scorpion antivenoms, that should adequately neutralize the scorpion venoms, obviating the need for laboratory experiments and reducing the risk of hypersensitivity to the antivenoms.

CONFLICT OF INTEREST

None.

AUTHOR CONTRIBUTIONS

SA Saganuwan conceived the idea and wrote the manuscript.
  42 in total

1.  Monoclonal antibodies against the Androctonus australis hector scorpion neurotoxin I: characterisation and use for venom neutralisation.

Authors:  O Clot-Faybesse; M Juin; H Rochat; C Devaux
Journal:  FEBS Lett       Date:  1999-09-24       Impact factor: 4.124

2.  Age effects on the pharmacokinetics of tityustoxin from Tityus serrulatus scorpion venom in rats.

Authors:  E A Nunan; V Arya; G Hochhaus; V N Cardoso; T Moraes-Santos
Journal:  Braz J Med Biol Res       Date:  2004-03-03       Impact factor: 2.590

3.  Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy.

Authors:  Mohamed Naceur Krifi; Sandrine Savin; Marcel Debray; Cassian Bon; Mohamed El Ayeb; Valérie Choumet
Journal:  Toxicon       Date:  2005-02       Impact factor: 3.033

4.  Characterization of venom components from the scorpion Androctonus crassicauda of Turkey: peptides and genes.

Authors:  Figen Caliskan; Blanca Ines García; Fredy I V Coronas; Cesar V F Batista; Fernando Z Zamudio; Lourival D Possani
Journal:  Toxicon       Date:  2006-04-25       Impact factor: 3.033

5.  Proteomic analysis of the venom and characterization of toxins specific for Na+ - and K+ -channels from the Colombian scorpion Tityus pachyurus.

Authors:  Jacqueline Barona; Cesar V F Batista; Fernando Z Zamudio; Froylan Gomez-Lagunas; Enzo Wanke; Rafael Otero; Lourival D Possani
Journal:  Biochim Biophys Acta       Date:  2005-08-26

6.  Moving pieces in a proteomic puzzle: mass fingerprinting of toxic fractions from the venom of Tityus serrulatus (Scorpiones, Buthidae).

Authors:  A M Pimenta; R Stöcklin; P Favreau; P E Bougis; M F Martin-Eauclaire
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

Review 7.  Report of a WHO workshop on the standardization and control of antivenoms.

Authors:  R D G Theakston; D A Warrell; E Griffiths
Journal:  Toxicon       Date:  2003-04       Impact factor: 3.033

Review 8.  The cardiovascular system after scorpion envenomation. A review.

Authors:  M Gueron; R Ilia; S Sofer
Journal:  J Toxicol Clin Toxicol       Date:  1992

9.  Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes.

Authors:  L M Alvarenga; C R Diniz; C Granier; C Chávez-Olórtegui
Journal:  Toxicon       Date:  2002-01       Impact factor: 3.033

10.  [Toxicological and immunological aspects of scorpion venom (Tytius pachyurus): neutralizing capacity of antivenoms produced in Latin America].

Authors:  Jacqueline Barona; Rafael Otero; Vitelbina Núñez
Journal:  Biomedica       Date:  2004-03       Impact factor: 0.935

View more
  2 in total

1.  Comparative therapeutic index, lethal time and safety margin of various toxicants and snake antivenoms using newly derived and old formulas.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  BMC Res Notes       Date:  2020-06-16

2.  Toxicity and protein composition of venoms of Hottentotta saulcyi, Hottentotta schach and Androctonus crassicauda, three scorpion species collected in Iran.

Authors:  Ani Boghozian; Habibollah Nazem; Mohammad Fazilati; Seyed Hossein Hejazi; Mohammadreza Sheikh Sajjadieh
Journal:  Vet Med Sci       Date:  2021-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.